Literature DB >> 17348842

NF-kappa B signaling and carcinogenesis.

Takashi Okamoto1, Takaomi Sanda, Kaori Asamitsu.   

Abstract

NF-kappaB is an inducible transcription factor that is controlled by the signal activation cascades. NF-kappaB controls a number of genes involved in immuno-inflammatory responses, cell cycle progression, inhibition of apoptosis and cell adhesion, thus promoting carcinogenesis and cancer progression. Interestingly, some proteins encoded by oncogenes and oncogenic viruses have been shown to be involved in NF-kappaB activation pathway. In fact, NF-kappaB is constitutively activated in some cancer and leukemia cells. These findings have substantiated the old concept of the link between chronic inflammation and carcinogenesis. In this review, we have attempted to overview the possible involvement of NF-kappaB in cancer and discuss the feasibility of anti-cancer strategy with NF-kappaB and its signaling cascade as novel molecular targets.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17348842     DOI: 10.2174/138161207780162944

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  38 in total

1.  Characterization and mechanistic studies of a novel melanoma-targeting construct containing IκBa for specific inhibition of nuclear factor-κB activity.

Authors:  Hong Zhou; Yuying Liu; Lawrence H Cheung; Sehoon Kim; Weihe Zhang; Khalid A Mohamedali; Preetha Anand; Walter N Hittelman; Bharat B Aggarwal; Michael G Rosenblum
Journal:  Neoplasia       Date:  2010-10       Impact factor: 5.715

2.  Identification of N-(quinolin-8-yl)benzenesulfonamides as agents capable of down-regulating NFkappaB activity within two separate high-throughput screens of NFkappaB activation.

Authors:  Yuli Xie; ShiXian Deng; Craig J Thomas; Yidong Liu; Ya-Qin Zhang; Alison Rinderspacher; Wenwei Huang; Gangli Gong; Michael Wyler; Efithia Cayanis; Nathalie Aulner; Udo Többen; Caty Chung; Sergey Pampou; Noel Southall; Dusica Vidović; Stephan Schürer; Lars Branden; R Eric Davis; Louis M Staudt; James Inglese; Christopher P Austin; Donald W Landry; Deborah H Smith; Douglas S Auld
Journal:  Bioorg Med Chem Lett       Date:  2007-10-30       Impact factor: 2.823

3.  Inhibition of Akt signaling in hepatoma cells induces apoptotic cell death independent of Akt activation status.

Authors:  Francesca Buontempo; Tulin Ersahin; Silvia Missiroli; Serif Senturk; Daniela Etro; Mehmet Ozturk; Silvano Capitani; Rengul Cetin-Atalay; Maria Luca Neri
Journal:  Invest New Drugs       Date:  2010-07-14       Impact factor: 3.850

4.  Effects of probucol on cell proliferation in human ovarian cancer cells.

Authors:  Lea-Yea Chuang; Jinn-Yuh Guh; Yi-Ling Ye; Ying-Ho Lee; Jau-Shyang Huang
Journal:  Toxicol Res (Camb)       Date:  2015-12-10       Impact factor: 3.524

5.  Astrocyte-derived CCL20 reinforces HIF-1-mediated hypoxic responses in glioblastoma by stimulating the CCR6-NF-κB signaling pathway.

Authors:  Peng Jin; Seung-Hyun Shin; Yang-Sook Chun; Hyun-Woo Shin; Yong Jae Shin; Yeri Lee; Donggeon Kim; Do-Hyun Nam; Jong-Wan Park
Journal:  Oncogene       Date:  2018-03-14       Impact factor: 9.867

6.  Hepatocellular alterations and dysregulation of oncogenic pathways in the liver of transgenic mice overexpressing growth hormone.

Authors:  Johanna G Miquet; Thomas Freund; Carolina S Martinez; Lorena González; María E Díaz; Giannina P Micucci; Elsa Zotta; Ravneet K Boparai; Andrzej Bartke; Daniel Turyn; Ana I Sotelo
Journal:  Cell Cycle       Date:  2013-02-21       Impact factor: 4.534

7.  Akt-mediated regulation of NFkappaB and the essentialness of NFkappaB for the oncogenicity of PI3K and Akt.

Authors:  Dong Bai; Lynn Ueno; Peter K Vogt
Journal:  Int J Cancer       Date:  2009-12-15       Impact factor: 7.396

8.  Gene and microRNA analysis of neutrophils from patients with polycythemia vera and essential thrombocytosis: down-regulation of micro RNA-1 and -133a.

Authors:  Stefanie Slezak; Ping Jin; Lorraine Caruccio; Jiaqiang Ren; Michael Bennett; Nausheen Zia; Sharon Adams; Ena Wang; Joao Ascensao; Geraldine Schechter; David Stroncek
Journal:  J Transl Med       Date:  2009-06-04       Impact factor: 5.531

9.  Glycogen synthase kinase-3 inhibition disrupts nuclear factor-kappaB activity in pancreatic cancer, but fails to sensitize to gemcitabine chemotherapy.

Authors:  Shadi Mamaghani; Satish Patel; David W Hedley
Journal:  BMC Cancer       Date:  2009-04-30       Impact factor: 4.430

10.  Genotype-dependent tumor regression in Marek's disease mediated at the level of tumor immunity.

Authors:  Shyamesh Kumar; Joram J Buza; Shane C Burgess
Journal:  Cancer Microenviron       Date:  2009-03-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.